Rani Therapeutics Holdings, Inc. (RANI) Revenue Growth
Rani Therapeutics Holdings, Inc. (RANI) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2022-12-31 | N/A |
| 2023-12-31 | N/A |
| 2024-12-31 | N/A |
| 2025-12-31 | 58.85% |
How RANI compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| AXSM | Axsome Therapeutics Inc. | 65.55% |
| ALNY | Alnylam Pharmaceuticals Inc. | 65.19% |
| IOVA | Iovance Biotherapeutics Inc. | 60.60% |
| AGIO | Agios Pharmaceuticals Inc. | 48.03% |
| LLY | Eli Lilly and Company | 44.70% |
These are five companies in the same sector as RANI with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Rani Therapeutics Holdings, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("RANI", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RANI | $0.86 | +1.25% | 1.16M |
| 3 | ||||
| 4 | ||||
| 5 |